Provention Bio, Inc. Contracts & Agreements

Warrant Agreement, dated February 2, 2023, issued by Provention Bio, Inc. (, Exhibit 4.6) (Filed With SEC on March 29, 2023)

Amendment No. 1 to the Asset Purchase Agreement between Provention Bio, Inc. and MacroGenics, Inc., dated November 30, 2022 (, Exhibit 10.29) (Filed With SEC on March 29, 2023)

First Amendment to Loan and Security Agreement, dated February 2, 2023, between Provention Bio, Inc. and Hercules Capital Inc. (, Exhibit 10.30) (Filed With SEC on March 29, 2023)

Co-Promotion Agreement, dated October 4, 2022, between Provention Bio, Inc. and Genzyme Corporation (Filed With SEC on March 24, 2023)

Securities Purchase Agreement, dated October 4, 2022, between Provention Bio, Inc. and Aventis Inc (Filed With SEC on March 24, 2023)

Agreement and Plan of Merger, dated as of March 12, 2023, among the Company, Parent and Purchaser (pursuant to Item 601(a)(5) of Regulation S-K, the Company hereby agrees to... (Filed With SEC on March 13, 2023)

Second Amendment to First Amended Employment Agreement, dated March 9, 2023, by and between the Company and Ashleigh Palmer (Filed With SEC on March 13, 2023)

Second Amendment to Employment Agreement, dated March 9, 2023, by and between the Company and Thierry Chauche (Filed With SEC on March 13, 2023)

Second Amendment to First Amended Employment Agreement, dated March 9, 2023, by and between the Company and Eleanor Ramos (Filed With SEC on March 13, 2023)

Letter Agreement, dated March 12, 2023, by and between the Company and Ashleigh Palmer (Filed With SEC on March 13, 2023)

Letter Agreement, dated March 12, 2023, by and between the Company and Thierry Chauche (Filed With SEC on March 13, 2023)

Letter Agreement, dated March 12, 2023, by and between the Company and Eleanor Ramos (Filed With SEC on March 13, 2023)

Warrant Agreement, dated September 15, 2022, issued by Provention Bio, Inc. (, Exhibit 4.1) (Filed With SEC on November 3, 2022)

Loan and Security Agreement, dated August 31, 2022, between Provention Bio, Inc. and Hercules Capital, Inc. (, Exhibit 10.1) (Filed With SEC on November 3, 2022)

Amendment to First Amended Employment Agreement dated May 19, 2020, effective September 9, 2022, between Provention Bio, Inc. and Ashleigh Palmer (, Exhibit 10.2) (Filed With SEC on November 3, 2022)

Amendment to Employment Agreement dated December 1, 2021, effective September 9, 2022, between Provention Bio, Inc. and Thierry Chauche (, Exhibit 10.3) (Filed With SEC on November 3, 2022)

Amendment to First Amended Employment Agreement dated June 9, 2020, effective September 9, 2022, between Provention Bio, Inc. and Eleanor Ramos (, Exhibit 10.4) (Filed With SEC on November 3, 2022)

Form of Warrant to Purchase Stock, dated as of July 7, 2022, issued by Provention Bio, Inc (Filed With SEC on July 8, 2022)

Form of Purchase Agreement, dated as of July 7, 2022, among Provention Bio, Inc. and each Purchaser party thereto (Filed With SEC on July 8, 2022)

Scientific Advisor Agreement, dated June 1, 2022, between Provention Bio, Inc. and Jeffrey Bluestone (Filed With SEC on June 3, 2022)

Provention Bio, Inc. 2020 Inducement Plan, as amended (Filed With SEC on May 20, 2022)

Description of Registrants Securities (Filed With SEC on February 24, 2022)

Transition Agreement, dated November 1, 2021, between Provention and Andrew Drechsler (Filed With SEC on February 24, 2022)

Employment Agreement, dated December 1, 2021, between Provention and Thierry Chauche (Filed With SEC on February 24, 2022)

Form of Stock Option Award under Provention Bio, Inc. 2020 Inducement Plan (, Exhibit 10.1) (Filed With SEC on May 6, 2021)

Sales Agreement, dated as of February 26, 2021, by and among Provention Bio, Inc., SVB Leerink LLC and Cantor Fitzgerald & Co (Filed With SEC on February 26, 2021)

Description of Registrants Securities (Filed With SEC on February 25, 2021)

Underwriting Agreement, dated January 13, 2021, among Provention Bio, Inc. and SVB Leerink LLC and Cantor Fitzgerald & Co., as representatives of the several underwriters (Filed With SEC on January 15, 2021)

Employment Agreement, effective August 3, 2020, between the Company and Heidy Abreu King-Jones (Filed With SEC on August 6, 2020)

Underwriting Agreement, dated June 17, 2020, by and among Provention Bio, Inc. and SVB Leerink LLC and Cantor Fitzgerald & Co., as representatives of the underwriters (Filed With SEC on June 18, 2020)

First Amended Employment Agreement, effective June 9, 2020, between the Company and Andrew Drechsler (Filed With SEC on June 11, 2020)

First Amended Employment Agreement, effective June 9, 2020, between the Company and Jason Hoitt (Filed With SEC on June 11, 2020)

First Amended Employment Agreement, effective June 10, 2020, between the Company and Francisco Leon (Filed With SEC on June 11, 2020)

First Amended Employment Agreement, effective June 9, 2020, between the Company and Eleanor Ramos (Filed With SEC on June 11, 2020)

First Amended Employment Agreement, effective May 19, 2020, between the Company and Ashleigh Palmer (Filed With SEC on May 20, 2020)

Description of Registrants Securities (, Exhibit 4.4) (Filed With SEC on March 12, 2020)

Employment Agreement, effective January 7, 2020, between the Company and Jason Hoitt (Filed With SEC on January 8, 2020)

Underwriting Agreement, dated September 18, 2019, by and between Provention Bio, Inc. and SVB Leerink LLC, as representative of the underwriters (Filed With SEC on September 19, 2019)

Subscription Agreement, dated September 18, 2019, by and between Provention Bio, Inc. and Amgen, Inc (Filed With SEC on September 19, 2019)

Form of Underwriting Agreement (Filed With SEC on June 10, 2019)

Form of Subscription Agreement with Amgen, Inc (Filed With SEC on June 10, 2019)

License and Collaboration Agreement by and between Provention and Amgen, Inc. dated November 5, 2018 (, Exhibit 10.23) (Filed With SEC on March 19, 2019)

Specimen Certificate representing shares of common stock of Provention (Filed With SEC on June 20, 2018)

License Agreement by and between Provention and MacroGenics, Inc. dated May 7, 2018 (Filed With SEC on June 20, 2018)

Asset Purchase Agreement by and between Provention and MacroGenics, Inc. dated May 7, 2018 (Filed With SEC on June 20, 2018)

Form of Escrow Deposit Agreement for the offering (Filed With SEC on June 20, 2018)

Form of Underwriting Agreement (Filed With SEC on June 12, 2018)

Form of Underwriters Warrant (Filed With SEC on June 12, 2018)

License, Development and Commercialization Agreement by and between Provention and Janssen Pharmaceutica NV (CSF-1R), dated April 25, 2017 (Filed With SEC on June 12, 2018)

Development Services Agreement by and between Provention and Intravacc dated March 6, 2018 (Filed With SEC on June 12, 2018)

License Agreement by and between Provention and MacroGenics, Inc. dated May 7, 2018 (Filed With SEC on June 12, 2018)

Asset Purchase Agreement by and between Provention and MacroGenics, Inc. dated May 7, 2018 (Filed With SEC on June 12, 2018)

Form of Subscription Agreement for the offering (Filed With SEC on June 12, 2018)

Form of Amended and Restated 2017 Provention Bio, Inc. Stock Incentive Plan (Filed With SEC on June 12, 2018)

Form of Warrant dated May 7, 2018, issued to MacroGenics, Inc (Filed With SEC on May 16, 2018)

Development Services Agreement by and between Provention and Intravacc dated March 6, 2018 (Filed With SEC on May 16, 2018)

License Agreement by and between Provention and MacroGenics, Inc. dated May 7, 2018 (Filed With SEC on May 16, 2018)

Asset Purchase Agreement by and between Provention and MacroGenics, Inc. dated May 7, 2018 (Filed With SEC on May 16, 2018)

2017 Provention Bio, Inc. Stock Incentive Plan (Filed With SEC on May 9, 2018)

Form of Stock Option Award under 2017 Provention Bio, Inc. Stock Incentive Plan (Filed With SEC on May 9, 2018)

Form of Lock-Up Agreement with MDB Capital Group, LLC (Filed With SEC on May 9, 2018)

License Agreement by and between Provention and Vactech Ltd., dated April 25, 2017 (Filed With SEC on May 9, 2018)

License, Development and Commercialization Agreement by and between Provention and Janssen Pharmaceutica NV (CSF-1R), dated April 25, 2017 (Filed With SEC on May 9, 2018)

License, Development and Commercialization Agreement by and between Provention and Janssen Sciences Ireland UC (TLR3), dated April 25, 2017 (Filed With SEC on May 9, 2018)

Form of Securities Purchase Agreement between Provention and investors for an offering completed on April 25, 2017 (Filed With SEC on May 9, 2018)

Form of Registration Rights Agreement between Provention and investors for an offering completed on April 25, 2017 (Filed With SEC on May 9, 2018)

Form of Voting Agreement between Provention and investors for an offering completed on April 25, 2017 (Filed With SEC on May 9, 2018)

Form of Right of First Refusal and Co-Sale Agreement between Provention and investors for an offering completed on April 25, 2017 (Filed With SEC on May 9, 2018)

Employment Agreement, dated April 25, 2017, between Provention and Ashleigh Palmer (Filed With SEC on May 9, 2018)

Employment Agreement, dated April 25, 2017, between Provention and Francisco Leon (Filed With SEC on May 9, 2018)

Employment Agreement, dated June 20, 2017, between Provention and Eleanor Ramos (Filed With SEC on May 9, 2018)

Employment Agreement, dated September 21, 2017, between Provention and Andrew Drechsler (Filed With SEC on May 9, 2018)

Form of Warrant dated April 25, 2017, issued to MDB Capital Group, LLC (Filed With SEC on May 9, 2018)

Engagement Agreement dated September 19, 2016, between Provention and MDB Capital Group, LLC (Filed With SEC on May 9, 2018)

Form of Indemnification Agreement entered into by Provention with its Officers and Directors (Filed With SEC on May 9, 2018)